Paper40698129
Unraveling the therapeutic landscape of approved non-peptide macrocycles.
Li Z and 2 others. Acta Pharm Sin B, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Unraveling the therapeutic landscape of approved non-peptide macrocycles. Papers, record 40698129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40698129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References183
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21923589 | Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection. | Pharmacotherapy | 2011 | https://conductscience.org/library/papers/21923589 | PubMed |
| 2 | 29249240 | Recent advances in the synthesis of cyclic pseudopeptides. | Drug Discov Today Technol | 2017 | https://conductscience.org/library/papers/29249240 | PubMed |
| 3 | 14709862 | Recent developments in the maytansinoid antitumor agents. | Chem Pharm Bull (Tokyo) | 2004 | https://conductscience.org/library/papers/14709862 | PubMed |
| 4 | 33207094 | First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer. | N Engl J Med | 2020 | https://conductscience.org/library/papers/33207094 | PubMed |
| 5 | 20104527 | Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. | Int J Cancer | 2010 | https://conductscience.org/library/papers/20104527 | PubMed |
| 6 | 38179950 | Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn? | J Med Chem | 2024 | https://conductscience.org/library/papers/38179950 | PubMed |
| 7 | 32309620 | FDA approved antibacterial drugs: 2018-2019. | Discoveries (Craiova) | 2019 | https://conductscience.org/library/papers/32309620 | PubMed |
| 8 | 32764876 | Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy. | Drug Des Devel Ther | 2020 | https://conductscience.org/library/papers/32764876 | PubMed |
| 9 | 38279972 | Repotrectinib: First Approval. | Drugs | 2024 | https://conductscience.org/library/papers/38279972 | PubMed |
| 10 | 26464510 | Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26464510 | PubMed |
| 11 | 28077299 | Anaplastic lymphoma kinase (ALK) inhibitors in the treatment of ALK-driven lung cancers. | Pharmacol Res | 2017 | https://conductscience.org/library/papers/28077299 | PubMed |
| 12 | 23636326 | mTOR kinase structure, mechanism and regulation. | Nature | 2013 | https://conductscience.org/library/papers/23636326 | PubMed |
| 13 | 36286339 | Going Viral: An Investigation into the Chameleonic Behaviour of Antiviral Compounds. | Chemistry | 2023 | https://conductscience.org/library/papers/36286339 | PubMed |
| 14 | 27931243 | Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies. | J Hematol Oncol | 2016 | https://conductscience.org/library/papers/27931243 | PubMed |
| 15 | 15560755 | Pimecrolimus -- an anti-inflammatory drug targeting the skin. | Exp Dermatol | 2004 | https://conductscience.org/library/papers/15560755 | PubMed |
| 16 | 24446688 | Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor. | J Med Chem | 2014 | https://conductscience.org/library/papers/24446688 | PubMed |
| 17 | 20739560 | Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice. | J Neurosci | 2010 | https://conductscience.org/library/papers/20739560 | PubMed |
| 18 | 12815382 | The bicyclam AMD3100 story. | Nat Rev Drug Discov | 2003 | https://conductscience.org/library/papers/12815382 | PubMed |
| 19 | 32274129 | Long-term safety of icotinib in patients with non-small cell lung cancer: a retrospective, real-world study. | J Thorac Dis | 2020 | https://conductscience.org/library/papers/32274129 | PubMed |
| 20 | 22543468 | Finding the sweet spot: the role of nature and nurture in medicinal chemistry. | Nat Rev Drug Discov | 2012 | https://conductscience.org/library/papers/22543468 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42819957 | All-Hydrocarbon Macrocycle Enables Highly Potent Th1-Biased NKT Cell Agonists for Immunotherapy. | JACS Au | 2026 | https://conductscience.org/library/papers/42819957 | PubMed |
| 42434599 | Computational QSAR and structure-based identification of plerixafor-derived PIM-1 kinase inhibitors in diffuse large B-Cell lymphoma. | Front Chem | 2026 | https://conductscience.org/library/papers/42434599 | PubMed |
| 41982728 | Synthesis and LCMS Characterization of a 1275-Member Library of 24-Atom Triazine Macrocycles Derived from Quantitative Dimerization Occurring with >99.9% Fidelity. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/41982728 | PubMed |
| 41746526 | Advancement in peptide-based therapeutics for the treatment of type 2 diabetes mellitus: current progress and future prospects. | Mol Divers | 2026 | https://conductscience.org/library/papers/41746526 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40698129
GET https://conductscience.org/api/papers/v1/40698129/references?page=2